ÂÜÀòÂÒÂ×

Maggie A. Pax is an accomplished executive with extensive experience in the life sciences and healthcare sectors. Currently, Maggie serves as a member of the Board of Directors for Repligen Corporation, Alimera, and Jellagen, contributing to innovations in bioprocessing, ophthalmology, and regenerative medicine. Additionally, Maggie acts as a Strategic Advisor for Crescent Strategic Growth Advisory, LLC, providing insights on growth and governance strategies for technology companies. Previous roles include significant positions at BioPorto Diagnostics and Thermo Fisher Scientific, where Maggie led strategy and innovation efforts. With a robust background that includes business development and marketing leadership at various healthcare firms, Maggie holds an M.B.A. from Harvard Business School.